Metabolix Announces Termination of Telles Joint Venture

Metabolix, Inc. MBLX, today announced that the Archer Daniels Midland Company has given notice of termination of the Telles, LLC joint venture for PHA bioplastics. The effective date of the termination will be February 8, 2012. Metabolix will hold a webcast conference call for investors today at 5:00 pm EST.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsEventsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!